Mark E. Saad - 03 Jun 2022 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/S/ Herriot Tabuteau, M.D., Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
03 Jun 2022
Net transactions value
$0
Form type
4
Filing time
07 Jun 2022, 16:08:05 UTC
Previous filing
08 Mar 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXSM Stock Option (Right to Buy) Award $0 +16,976 $0.000000 16,976 03 Jun 2022 Common Stock 16,976 $25.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the one-year anniversary of the date of grant, June 3, 2023.